Therapeutic aspects of spondyloarthropathies - A review

Scandinavian Journal of Rheumatology

Volumn 27, Issue 5, 1998, Pages 323-328

  Leirisalo Repo, M ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Chlamydia; HLA B27; Reactive arthritis; Reiter's disease; Spondyloarthropathy; Sulfasalazine; Tetracycline; Yersinia

Indexed keywords

AMITRIPTYLINE; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; AZATHIOPRINE; CIPROFLOXACIN; DOXYCYCLINE; GOLD; METHOTREXATE; MINOCYCLINE; OXYTETRACYCLINE; PLACEBO; SALAZOSULFAPYRIDINE;

ANTIBIOTIC THERAPY; BACTERIAL ARTHRITIS; CASE REPORT; CHLAMYDIA TRACHOMATIS; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LOW BACK PAIN; META ANALYSIS; ORAL DRUG ADMINISTRATION; PHYSIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; REACTIVE ARTHRITIS; REITER SYNDROME; REVIEW; SALMONELLA; SHIGELLA; SPONDYLOARTHROPATHY; YERSINIA ENTEROCOLITICA;

ANTI-BACTERIAL AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, INFECTIOUS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DISEASE PROGRESSION; HUMANS; INFLAMMATION; PROGNOSIS; SPONDYLITIS, ANKYLOSING; SULFASALAZINE; TETRACYCLINE;

EID: 0031724829     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009749850154320     Document Type: Review

References (71)

1. Keat A. Reiter's syndrome and reactive arthritis in perspective. N Engl J Med 1983;309:1606-15.
2. Khan MA. A worldwide overview: the epidemiology of HLA-B27 and associated spondyloarthritides. In: Calin A, Taurog J, eds. The spondylarthritides. Oxford: Oxford University Press, 1998:17-26.
3. Keat AC, Thomas B, Dixey J, Oshorn M, Sonnex C, Taylor-Robinson D. Chlamydia trachomatis and reactive arthritis: the missing link. Lancet 1987;1:72-4.
4. Schumacher HR Jr, Magge S, Cherian PV, Sleckman J, Rothfuss S, Clayburne G, et al. Light and electron microscopic studies on the synovial membrane in Reiter's syndrome. Arthritis Rheum 1988;31:937-46.
5. Zeidler HK, Schumacher HR Jr. Chlamydia-induced arthritis. In: Calin A, Taurog J, eds. The spondylarthritides. Oxford: Oxford University Press, 1998:70-96.
6. Granfors K, Jalkanen S, von Essen R, Lahesmaa-Rantala R, Isomäki O, Pekkola-Heino K, et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 1989;320:216-21.
7. Granfors K, Jalkanen S, Lindberg AA, Mäki-Ikola O, von Essen R, Lahesmaa-Rantala R, et al. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet 1990;335:685-8.
8. Granfors K, Jalkanen S, Toivanen P, Koski J, Lindberg AA. Bacterial lipopolysaccharide in synovial fluid cells in shigella-triggered reactive arthritis. J Rheumatol 1992;19:300.
9. Bas S, Griffais R, Kvien T, Glennäs A, Melhy K, Vischer TL. Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthritis. Arthritis Rheum 1995;38:1005-13.
10. Taylor-Robinson D, Gilroy CB, Thomas BJ, Keat ACS. Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction. Lancet 1992;340:81-2.
11. Rahman RU, Cheema MA, Schumacher HR, Hudson AP. Molecular evidence for the presence of chlamydia in the synovium of patients with Reiter's syndrome. Arthritis Rheum 1992;35:521-9.
12. Schachler J, Barnes MG, Jones JP, Engleman EP, Meyer KF. Isolation of bedsoniae from the joints of patients with Reiter's syndrome. Proc Soc Exp Biol Med 1966;122:283-5.
13. Vilppula AH, Yli-Kettlula UI, Ahlroos AK, Terho PE. Chlamydial isolations and serology in Reiter's syndrome. Scand J Rheumalol 1981;10:181-5.
14. Hammer M, Zeidler H, Klimsa S, Heesemann J. Yersinia enterocolitica in the synovial membrane of patients with yersinia-induced arthritis. Arthritis Rheum 1990;33:1795-800.
15. Leirisalo M, Skylv G, Kousa M, Voipio-Pulkki L-M, Suoranla H, Nissilä M, et al. Follow-up study on patients with Reiter's disease and with reactive arthritis, with special reference to HLA-B27. Arthritis Rheum 1982;25: 249-59.
16. Fox R, Calin A, Gerber RC, Gibson D. The chronicity of symptoms and disability in Reiter's syndrome. Ann Intern Med 1979;91:90-3.
17. Zeidler H. Undifferentiated arthritis and spondylarthropathy as a major problem of diagnosis and classification. Scand J Rheumatol 1987;16 Suppl 65:54-62.
18. Braun J, Laitko S, Treharne J, Eggens U, Wu P, Distler A, et al. Chlamydia pneumoniae a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis 1994;53:100-5.
19. Sieper J, Braun J, Brandt J, Miksits K, Heesemann J, Laitko S, et al. Pathogenetic role of Chlamydia, Yersinia and Borrelia in undifferentiated oligoarthritis. J Rheumatol 1992;19:1236-42.
20. Ebringer A. Ankylosing spondylilis is caused by Klebsiella. Evidence from immunogenetic, microbiologic, and serologic studies. Rheum Dis Clin North Am 1992;18:105-21.
21. Russell AS, Almazor MES. Ankylosing spondylitis is not caused by Klebsiella. Rheum Dis Clin North Am 1992;18: 95-104.
22. Schwimmbeck PL, Yu DTY, Oldslone MBA. Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med 1987;166:173-81.
23. Husby G, Tsuchiya N, Schwimmbeck PL, Keat A, Pahle JA, Oldstone MB, et al. Crossreactive epitope with Klebsiella pneumoniae nitrogenase in articular tissue of HLA-B27 + patients with ankylosing spondylitis. Arthritis Rheum 1989;32:437-45.
24. Aho K, Leirisalo-Repo M, Repo H. Reactive arthritis. Clin Rheum Dis 1985;11:25-40.
25. Bardin T, Enel C, Cornelis F, Salski C, Jorgensen C, Ward R, et al. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum 1992;35:190-4.
26. Gordis L. Effectiveness of comprehensive-care programs in preventing rheumatic fever. N Engl J Med 1973;289:331-5.
27. Leirisalo-Repo M, Skylv G, Kousa M. Follow-up of Reiter's disease and reactive arthritis. Factors influencing the natural course and the prognosis. Clin Rheumatol 1987;6 Suppl 2: 73-82.
28. Frydén A, Bengtsson A, Foberg U, Svenungsson B, Castor B, Karnell A, et al. Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study. Br Med J 1990;301:1299-302.
29. Lauhio A, Leirisalo-Repo M, Lähdevirta J, Saikku P, Repo H. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 1991;34:6-14.
30. Sieper J, Fendler C, Eggens U, Laitko S, Sörensen H, Keitel W, et al. Long-term antibiotic treatment in reactive arthritis (REA) and undifferentiated oligoarthritis (UOA): results of a double-blinded placebo-controlled randomized study. Abstract. Arthritis Rheum 1997;40:S227.
31. Hoogkamp-Korstanje JAA. Antibiotics in Yersinia enterocolitica infections. J Antimicrob Chemother 1987;20:123-31.
32. Pott H-G, Wittenborg A, Junge-Hülsing G. Long-term antibiotic treatment in reactive arthritis. Lancet 1988:i:245-6.
33. Panayi GS, Clark B. Minocycline in the treatment of patients with Reiter's syndrome. Clin Exp Rheumatol 1989;7:100-1.
34. Kloppenburg M, Breedveld F, Terweil JP, Mallee C, Dijkmans BA. Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial. Arthritis Rheum 1994;37: 629-36.
35. Zachariae H, From E, Zachariae E. Reiter's disease and prostatitis. Treatment with tetracycline. Ugeskr Laeger 1979;141: 2058-9.
36. Olhagen B. Chronic uro-polyarthritis in the male. Acta Med Scand 1960;168:339-45.
37. Popert AJ, Gill AJ, Laird SM. A prospective study of Reiter's syndrome: an interim report on the first 82 cases. Br J Vener Dis 1964;40:160-5.
38. Wollenhaupt J, Hammer M, Pott HG, Zeidler H. A double-blind, placebo-controlled comparison of 2 weeks versus 4 months treatment with doxycycline in chlamydia-induced reactive arthritis. Abstract. Arthritis Rheum 1997;40:8143.
39. Toivanen A, Yli-Kerttula T, Luukkainen R, Merilahti-Palo R, Granfors K, Seppälä J. Effect of antimicrobial treatment on chronic reactive arthritis. Clin Exp Rheumatol 1993;11:301-7.
40. Dekker-Saeys BJ, Meuwissen SGM, van den Berg-Loonen EM, de Haas WHD, Agenant D, Tytgat GNJ. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel disease. Ann Rheum Dis 1978;37:33-5.
41. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine 1976;55:401-12.
42. Haslock I, Wright V. The musculo-sceletal complications of Crohn's disease. Medicine 1973;52:217-25.
43. Wright V, Watkinson G. Sacro-iliitis and ulcerative colitis. Br Med J 1965;2:675-80.
44. Moll JM. Inflammatory bowel disease. Clin Rheum Dis 1985;11:87-111.
45. Meuwissen SGM, Dekker-Saeys BJ, Agenant D, Tytgat GNJ. Ankylosing spondylitis and inflammatory bowel disease. Ann Rheum Dis 1978;37:30-2.
46. Mielants H, Veys EM, Goemaere S, Cuvelier C, De Vos M. A prospective study of patients with spondyloarthropathy with special reference to HLA-B27 and to gut histology. J Rheumatol 1993;20:1353-8.
47. Leirisalo-Repo M, Turunen U, Stenman S, Helenius P, Seppälä K. High frequency of silent inflammatory bowel disease in spondyloarthropathy. Arthritis Rheum 1994;37:23-31.
48. Leirisalo-Repo M, Repo H. Gut and spondyloarthropathies. Rheum Dis Clin North Am 1992;18:23-35.
49. Egsmose C, Hansen TM, Andersen LS, Beier M, Chridtiansen L, Ejstrup L, et al. Limited effect of sulphasalazine treatment in reactive arthritis. A randomized double blind placebo controlled trial. Ann Rheum Dis 1997;56:32-6.
50. Dougados M, van den Linden S, Leirisalo-Repo M, Huitfeldt B, Juhlin R, Veys E, et al. Sulfasalazine in the treatment of spondylarthropathy: a randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum 1995;38:618-27.
51. Clegg DO, Reda DJ, Weisman MH, Cush JJ, Vasey FB, Schumacher HR Jr, et al. Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 1996;39:2021-7.
52. Corkill MM, Jobanputra P, Gibson T, Macfarlane DG. A controlled trial of sulphasalazine treatment of chronic ankylosing spondylitis: Failure to demonstrate a clinical effect. Br J Rheumatol 1990;29:41-5.
53. Davis MJ, Dawes PT, Beswick E, Lewin IV, Stanworth DR. Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin. Br J Rheumatol 1989;28: 410-3.
54. Dougados M, Boumier P, Amor B. Sulphasalazine in ankylosing spondylitis: a double-blind controlled study in 60 patients. Br Med J 1986;293:911-4.
55. Feltelius N, Hällgren R. Sulphasalazine in ankylosing spondylitis. Ann Rheum Dis 1986;45:396-9.
56. Fraser SM, Sturrock RD. Evaluation of sulphasalazine in ankylosing spondylitis an interventional study. Br J Rheumatol 1990;29:37-9.
57. Nissilä M, Lehtinen K, Leirisalo-Repo M, Luukkainen R, Mutru O, Yli-Kerttula U. Sulfasalazine in the treatment of ankylosing spondylitis a 26-week placebo-controlled clinical trial. Arthritis Rheum 1988;31:1111-6.
58. Clegg DO, Reda DJ, Weisman MH, Blackburn WD, Cush JJ, Cannon GW, et al. Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A department of Veterans Affairs Cooperative Study. Arthritis Rheum 1996;39:2004-12.
59. Ferraz MB, Tugwell P, Goldsmith CH, Atra E. Meta-analysis of sulfasalazine in ankylosing spondylilis. J Rheumatol 1990;17:1482-6.
60. Kirwan J, Edwards A, Huitfeldt B, Thompson P, Currey H. The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years. Br J Rheumatol 1993;32:729-33.
61. Taylor HG, Beswick FJ, Dawes PT. Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment. Clin Rheumatol 1991;10:43-8.
62. Mielants H, Veys EM, Joos R. Sulphasalazine (Salazopyrin) in the treatment of enterogenic reactive synovilis and ankylosing spondylitis with peripheral arthritis. Clin Rheumatol 1986;5:80-3.
63. Gran JT, Husby O. Ankylosing spondylitis. Current drug treatment. Drugs 1992;44:585-603.
64. Rosenthal M. Is there a place for corticosteroids or immune modulation im treating Reiter's syndrome and ankylosing spondylitis? Ann Rheum Dis 1979;38 Suppl:100-1.
65. Yunus MB. Current therapeutic practices in spondyloarthropathies. Compr Ther 1988;14:54-64.
66. Creemers MCW, van Riel PLCM, Franssen MJAM, van de Putte LB, Gribnau BWJ. Second-line treatment in seronegative spondylarthropathies. Semin Arthritis Rheum 1994;24:71-8.
67. Repo H, Koivuranta-Vaara P, Leirisalo-Repo M, Lauharanta J, Österman T, Vapaatalo H. Etretinate therapy and neutrophil function in a patient with reactive arthritis triggered by Salmonella infantis. Clin Exp Rheumatol 1987;5:388-90.
68. Belz J, Breneman DL, Nordlund JJ, Solingen A. Successful treatment of a patient with Reiter's syndrome and acquired immunodeficiency syndrome using etretinate. J Am Acad Dermatol 1989;20:898-903.
69. Koh W-E, Pande I, Samuels A, Jones SD, Calin A. Low dose amitriptyline in ankylosing spondylilis: a short term, double blind, placebo controlled study. J Rheumatol 1997;24:2158-61.
70. Viitanen JV, Lehtinen K, Suni J, Kautiainen H. Fifteen months' follow-up of intensive inpatient physiotherapy and excercise in ankylosing spondylitis. Clin Rheumatol 1995;14:413-9.
71. Band DA, Jones SD, Kennedy LG, Garrett SL, Porter J, Gay L, et al. Which patients with ankylosing spondylitis derive most benefit from an inpatient management program? J Rheumatol 1997;24:2381-4.